Light and inherited retinal degeneration

British Journal of Ophthalmology

Volumn 90, Issue 8, 2006, Pages 1060-1066

  Paskowitz, D M ^a   LaVail, M M ^a   Duncan, Jacque L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GENE PRODUCT; PERIPHERIN; RETINA S ANTIGEN; RHODOPSIN; RHODOPSIN KINASE; TAURINE TRANSPORTER;

ANIMAL MODEL; AUTOSOMAL DOMINANT INHERITANCE; CONTROLLED STUDY; FRAMESHIFT MUTATION; GENE MUTATION; KNOCKOUT GENE; LIGHT; MOUSE; NONHUMAN; OGUCHI DISEASE; PRIORITY JOURNAL; RAT; RETINA DEGENERATION; RETINITIS PIGMENTOSA; REVIEW; RNA SPLICING; STARGARDT DISEASE;

ANIMALS; CORNEAL DYSTROPHIES, HEREDITARY; DISEASE MODELS, ANIMAL; HUMANS; LIGHT; MICE; RATS; RETINAL DEGENERATION; RHODOPSIN;

EID: 33746495558     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.097436     Document Type: Review

References (172)

1. Berson EL. Light deprivation for early retinitis pigmentosa. A hypothesis. Arch Ophthalmol 1971;85:521-9.
2. Berson EL. Light deprivation and retinitis pigmentosa. Vis Res 1980;20:1179-84.
3. Miyake Y, Sugita S, Horiguchi M, et al. Light deprivation and retinitis pigmentosa. Am J Ophthalmol 1990;110:305-6.
4. Stone J, Maslim J, Valter-Kocsi K, et al. Mechanisms of photoreceptor death and survival in mammalian retina. Prog Retin Eye Res 1999;18:689-735.
5. Wenzel A, Grimm C, Samardzija M, et al. Molecular mechanisms of light-induced photoreceptor apoptosis and neuroprotection for retinal degeneration. Prog Retin Eye Res 2005;24:275-306.
6. Reme CE. The dark side of light: rhodopsin and the silent death of vision. The Proctor Lecture. Invest Ophthalmol Vis Sci 2005;46:2671-82.
7. Kiselev A, Socolich M, Vinos J, et al. A molecular pathway for light-dependent photoreceptor apoptosis in Drosophila. Neuron 2000;28:139-52.
8. Xu J, Dodd RL, Makino CL, et al. Prolonged photoresponses in transgenic mouse rods lacking arrestin. Nature 1997;389:505-9.
9. Chen J, Simon MI, Matthes MT, et al. Increased susceptibility to light damage in an arrestin knockout mouse model of Oguchi disease (stationary night blindness). Invest Ophthalmol Vis Sci 1999;40:2978-82.
10. Hao W, Wenzel A, Obin MS, et al. Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat Genet 2002;32:254-60.
11. Fuchs S, Nakazawa M, Maw M, et al. A homozygous 1-base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat Genet 1995;10:360-2.
12. Nakazawa M, Wada Y, Tamai M. Arrestin gene mutations in autosomal recessive retinitis pigmentosa. Arch Ophthalmol 1998;116:498-501.
13. Fernandez-Gonzalez A, La Spada AR, Treadaway J, et al. Purkinje cell degeneration (pcd) phenotypes caused by mutations in the axotomy-induced gene, Nna1. Science 2002;295:1904-6.
14. LaVail MM, Gorrin GM, Yasumura D, et al. Increased susceptibility to constant light in nr and pcd mice with inherited retinal degenerations. Invest Ophthalmol Vis Sci 1999;40:1020-4.
15. Van de Pavert SA, Kantardzhieva A, Malysheva A, et al. Crumbs homologue 1 is required for maintenance of photoreceptor cell polarization and adhesion during light exposure. J Cell Sci 2004;117:4169-77.
16. den Hollander AI, Davis J, van der Velde-Visser SD, et al. CRB1 mutation spectrum in inherited retinal dystrophies. Hum Mutat 2004;24:355-69.
17. McKay GJ, Clarke S, Davis JA, et al. Pigmented paravenous chorioretinal atrophy is associated with a mutation within the crumbs homolog 1 (CRB1) gene. Invest Ophthalmol Vis Sci 2005;46:322-8.
18. D'Cruz PM, Yasumura D, Weir J, et al. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet 2000;9:645-51.
19. Dowling JE, Sidman RL. Inherited retinal dystrophy in the rat. J Cell Biol 1962;14:73-109.
20. LaVail MM, Battelle BA. Influence of eye pigmentation and light deprivation on inherited retinal dystrophy in the rat. Exp Eye Res 1975;21:167-92.
21. Kaitz M, Auerbach E. Retinal degeneration in RCS rats raised under ambient light levels. Vision Res 1979;19:79-81.
22. Noell WK. Some animal models of retinitis pigmentosa. Adv Exp Med Biol 1977;77:87-91.
23. Organisciak DT, Li M, Darrow RM, et al. Photoreceptor cell damage by light in young Royal College of Surgeons rats. Curr Eye Res 1999;19:188-96.
24. Gal A, Li Y, Thompson DA, et al. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet 2000;26:270-1.
25. Ma J, Norton JC, Allen AC, et al. Retinal degeneration slow (rds) in mouse results from simple insertion of a t haplotype-specific element into protein-coding exon II. Genomics 1995;28:212-9.
26. Sanyal S, Hawkins RK. Development and degeneration of retina in rds mutant mice: effects of light on the rate of degeneration in albino and pigmented homozygous and heterozygous mutant and normal mice. Vis Res 1986;26:1177-85.
27. OMIM 179605, http://www.ncbi.nlm.nih.gov/Omim.
28. Kijas JW, Cideciyan AV, Aleman TS, et al. Naturally occurring rhodopsin mutation in the dog causes retinal dysfunction and degeneration mimicking human dominant retinitis pigmentosa. Proc Natl Acad Sci USA 2002;99:6328-33.
29. Cideciyan AV, Jacobson SG, Aleman TS, et al. In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa. Proc Natl Acad Sci USA 2005;102:5233-8.
30. Bunge S, Wedemann H, David D, et al. Molecular analysis and genetic mapping of the rhodopsin gene in families with autosomal dominant retinitis pigmentosa. Genomics 1993;17:230-3.
31. Van den Born LI, van Schooneveld MJ, de Jong LA, et al. Thr4Lys rhodopsin mutation is associated with autosomal dominant retinitis pigmentosa of the cone-rod type in a small Dutch family. Ophthalmic Genet 1994;15:51-60.
32. Naash MI, Hollyfield JG, al-Ubaidi MR, et al. Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene. Proc Natl Acad Sci USA 1993;90:5499-503.
33. Naash ML, Peachey NS, Li ZY, et al. Light-induced acceleration of photoreceptor degeneration in transgenic mice expressing mutant rhodopsin. Invest Ophthalmol Vis Sci 1996;37:775-82.
34. Wang M, Lam TT, Tso MO, et al. Expression of a mutant opsin gene increases the susceptibility of the retina to light damage. Vis Neurosci 1997;14:55-62.
35. Dryja TP, McGee TL, Reichel E, et al. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 1990;343:364-6.
36. Lewin AS, Drenser KA, Hauswirth WW, et al. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat Med 1998;4:967-71.
37. Machida S, Kondo M, Jamison JA, et al. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Scio 2000;41:3200-9.
38. Organisciak DT, Darrow RM, Barsalou L, et al. Susceptibility to retinal light damage in transgenic rats with rhodopsin mutations. Invest Ophthalmol Vis Sci 2003;44:486-92.
39. Nir I, Harrison JM, Liu C, et al. Extended photoreceptor viability by light stress in the RCS rats but not in the opsin P23H mutant rats. Invest Ophthalmol Vis Sci 2001;42:842-9.
40. Bicknell IR, Darrow R, Barsalou L, et al. Alterations in retinal rod outer segment fatty acids and light-damage susceptibility in P23H rats. Mol Vis 2002;8:333-40.
41. Vaughan DK, Coulibaly SF, Darrow RM, et al. A morphometric study of light-induced damage in transgenic rat models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 2003;44:848-55.
42. Walsh N, van Driel D, Lee D, et al. Multiple vulnerability of photoreceptors to mesopic ambient light in the P23H transgenic rat. Brain Res 2004;1013:194-203.
43. Chen CK, Burns ME, Spencer M, et al. Abnormal photoresponses and light-induced apoptosis in rods lacking rhodopsin kinase. Proc Natl Acad Sci USA 1999;96:3718-22.
44. Yamamoto S, Sippel KC, Berson EL, et al. Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat Genet 1997;15:175-8.
45. Weng J, Mata NL, Azarian SM, et al. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in aber knockout mice. Cell 1999;98:13-23.
46. Mata NL, Weng J, Travis GH. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci USA 2000;97:7154-9.
47. OMIM 601691, http://www.ncbi.nlm.nih.gov/Omim.
48. Redmond TM, Yu S, Lee E, ef al. Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet 1998;20:344-51.
49. Fan J, Woodruff ML, Cilluffo MC, et al. Opsin activation of transduction in the rods of dark-reared Rpe65 knockout mice. J Physiol 2005;568:83-95.
50. Grimm C, Wenzel A, Hafezi F, et al. Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. Nat Genet 2000;25:63-6.
51. Thompson DA, Gal A. Vitamin A metabolism in the retinal pigment epithelium: genes, mutations, and diseases. Prog Retin Eye Res 2003;22:683-703.
52. Heller-Stilb B, van Roeyen C, Rascher K, et al. Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J 2002;16:231-3.
53. Rascher K, Servos G, Berthold G, et al. Light deprivation slows but does not prevent the loss of photoreceptors in taurine transporter knockout mice. Vis Res 2004;44:2091-100.
54. Noben-Trauth K, Naggert JK, North MA, et al. A candidate gene for the mouse mutation tubby. Nature 1996;380:534-8.
55. Kleyn PW, Fan W, Kovats SG, et al. Identification and characterization of the mouse obesity gene tubby: a member of a novel gene family. Cell 1996;85:281-90.
56. Kong L, Li F, Soleman CE, et al. Bright cyclic light accelerates photoreceptor cell degeneration in tubby mice. Neurobiol Dis 2005;(in press).
57. Hagstrom SA, North MA, Nishina PL, et al. Recessive mutations in the gene encoding the tubby-like protein TULP1 in patients with retinitis pigmentosa. Nat Genet 1998;18:174-6.
58. Banerjee P, Kleyn PW, Knowles JA, et al. TULP1 mutation in two extended Dominican kindreds with autosomal recessive retinitis pigmentosa. Nat Genet 1998;18:177-9.
59. Hanein S, Perrault I, Gerber S, et al. Leber congenital amaurosis: comprehensive survey of the genetic heterogeneity, refinement of the clinical definition, and genotype-phenotype correlations as a strategy for molecular diagnosis. Hum Mutat 2004;23:306-17.
60. Mullen RJ, LaVail MM. Two types of retinal degeneration in cerebellar mutant mice. Nature 1975;258:528-30.
61. LaVail MM. Interaction of environmental light and eye pigmentation with inherited retinal degenerations. Vis Res 1980;20:1173-7.
62. Ranta S, Zhang Y, Ross B, et al. The neuronal ceroid lipofuscinoses in human EPMR and mnd mutant mice are associated with mutations in CLN8. Nat Genet 1999;23:233-6.
63. Messer A, Plummer J, MacMillen MC, et al. Genetics of primary and timing effects in the mnd mouse. Am J Med Genet 1995;57:361-4.
64. Ranta S, Topcu M, Tegelberg S, et al. Variant late infantile neuronal ceroid lipofuscinosis in a subset of Turkish patients is allelic to Northern epilepsy. Hum Mutat 2004;23:300-5.
65. Steingrimsson E, Moore KJ, Lamoreux ML, et al. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat Genet 1994;8:256-63.
66. Smith SB, Cope BK, McCoy JR. Effects of dark-rearing on the retinal degeneration of the C57BL/6-mivit/mivit mouse. Exp Eye Res 1994;58:77-84.
67. Tassobehji M, Newton VE, Read AP. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet 1994;8:251-5.
68. Smith SD, Kelley PM, Kenyon JB, et al. Tietz syndrome (hypopigmentation/deafness) caused by mutation of MITF. J Med Genet 2000;37:446-8.
69. Li T, Franson WK, Gordon JW, et al. Constitutive activation of phototransduction by K296E opsin is not a cause of photoreceptor degeneration. Proc Natl Acad Sci USA 1995;92:3551-5.
70. Keen TJ, Inglehearn CF, Lester DH, et al. Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of them in the retinal attachment site. Genomics 1991;11:199-205.
71. Liu C, Li Y, Peng M, et al. Activation of caspase-3 in the retina of transgenic rats with the rhodopsin mutation S334ter during photoreceptor degeneration. J Neurosci 1999;19:4778-85.
72. Green ES, Menz MD, LaVail MM, et al. Characterization of rhodopsin missorting and constitutive activation in a transgenic rat model of retinitis pigmentosa. Invest Ophthalmol Vis Sci 2000;41:1546-53.
73. Ranchon I, LaVail MM, Kotake Y, et al. Free radical trap phenyl-N-tert-bulylnitrone protects against light damage but does not rescue P23H and S334ter rhodopsin transgenic rats from inherited retinal degeneration. J Neurosci 2003;23:6050-7.
74. Humphries MM, Rancourt D, Farrar GJ, et al. Retinopathy induced in mice by targeted disruption of the rhodopsin gene. Nat Genet 1997;15:216-19.
75. Rosenfeld PJ, Cowley GS, McGee TL, et al. A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa. Nat Genet 1992;1:209-13.
76. Sung CH, Davenport CM, Hennessey JC, et al. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci USA 1991;88:6481-5.
77. Dryja TP, McEvoy JA, McGee TL, et al. Novel rhodopsin mutations Gly114Val and Gln184Pro in dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci 2000;41:3124-7.
78. Dryja TP, Hahn LB, Cowley GS, et al. Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci USA 1991;88:9370-4.
79. Cideciyan AV, Hood DC, Huang Y, et al. Disease sequence from mutant rhodopsin allele to rod and cone photoreceptor degeneration in man. Proc Natl Acad Sci USA 1998;95:7103-8.
80. Heckenlively JR, Rodriguez JA, Daiger SP. Autosomal dominant sectoral retinitis pigmentosa. Two families with transversion mutation in codon 23 of rhodopsin. Arch Ophthalmol 1991;109:84-91.
81. Berson EL, Rosner B, Sandberg MA, et al. Ocular findings in patients with autosomal dominant retinitis pigmentosa and a rhodopsin gene defect (Pro-23-His). Arch Ophthalmol 1991;109:92-101.
82. Jacobson SG, Kemp CM, Sung CH, et al. Retinal function and rhodopsin levels in autosomal dominant retinitis pigmentosa with rhodopsin mutations. Am J Ophthalmol 1991;112:256-71.
83. Fishman GA, Stone EM, Gilbert LD, et al. Ocular findings associated with a rhodopsin gene codon 58 transversion mutation in autosomal dominant retinitis pigmentosa. Arch Ophthalmol 1991;109:1387-93.
84. Stone EM, Kimura AE, Nichols BE, et al. Regional distribution of retinal degeneration in patients with the praline to histidine mutation in codon 23 of the rhodopsin gene. Ophthalmology 1991;98:1806-13.
85. Fishman GA, Stone EM, Sheffield VC, et al. Ocular findings associated with rhodopsin gene codon 17 and codon 182 transition mutations in dominant retinitis pigmentosa. Arch Ophthalmol 1992;110:54-62.
86. Kemp CM, Jacobson SG, Roman AJ, et al. Abnormal rod dark adaptation in autosomal dominant retinitis pigmentosa with proline-23-histidine rhodopsin mutation. Am J Ophthalmol 1992;113:165-74.
87. Fishman GA, Stone EM, Gilbert LD, et al. Ocular findings associated with a rhodopsin gene codon 106 mutation. Glycine-to-arginine change in autosomal dominant retinitis pigmentosa. Arch Ophthalmol 1992;110:646-53.
88. Moore AT, Fitzke FW, Kemp CM, et al. Abnormal dark adaptation kinetics in autosomal dominant sector retinitis pigmentosa due to rod opsin mutation. Br J Ophthalmol 1992;76:465-9.
89. Hayakawa M, Hotta Y, Imai Y, et al. Clinical features of autosomal dominant retinitis pigmentosa with rhodopsin gene codon 17 mutation and retinal neovascularization in a Japanese patient. Am J Ophthalmol 1993;115:168-73.
90. Li ZY, Jacobson SG, Milam AH. Autosomal dominant retinitis pigmentosa caused by the threonine-17-methionine rhodopsin mutation: retinal histopathology and immunocytochemistry. Exp Eye Res 1994;58:397-408.
91. Adrian W, Everson RW, Schmidt I. Protection against photic damage in retinitis pigmentosa. Adv Exp Med Biol 1977;77:233-47.
92. Schwartz L, Boelle PY, D'Hermies F, et al. Blue light dose distribution and retinitis pigmentosa visual field defects: an hypothesis. Med Hypotheses 2003;60:644-9.
93. Goto Y, Peachey NS, Ripps H, et al. Functional abnormalities in transgenic mice expressing a mutant rhodopsin gene. Invest Ophthalmol Vis Sci 1995;36:62-71.
94. Sung CH, Schneider BG, Agarwal N, et al. Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci USA 1991;88:8840-4.
95. Kaushal S, Khorana HG. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 1994;33:6121-8.
96. Liu X, Garriga P, Khorana HG. Structure and function in rhodopsin: correct folding and misfolding in two point mutants in the intradiscal domain of rhodopsin identified in retinitis pigmentosa. Proc Natl Acad Sci USA 1996;93:4554-9.
97. Saliba RS, Munro PM, Luthert PJ, et al. The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation. J Cell Sci 2002;115:2907-18.
98. Illing ME, Rajan RS, Bence NF, et al. A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J Biol Chem 2002;277:34150-60.
99. Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med 2004;10(Suppl):S10-7.
100. Alfinito PD, Townes-Anderson E. Activation of mislocalized opsin kills rod cells: a novel mechanism for rod cell death in retinal disease. Proc Natl Acad Sci USA 2002;99:5655-60.
101. Olsson JE, Gordon JW, Pawlyk BS, et al. Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa. Neuron 1992;9:815-30.
102. Roof DJ, Adamian M, Hayes A. Rhodopsin accumulation at abnormal sites in retinas of mice with a human P23H rhodopsin transgene. Invest Ophthalmol Vis Sci 1994;35:4049-62.
103. Wu TH, Ting TD, Okajima TI, et al. Opsin localization and rhodopsin photochemistry in a transgenic mouse model of retinitis pigmentosa. Neuroscience 1998;87:709-17.
104. Birch DG, Hood DC, Nusinowitz S, et al. Abnormal activation and inactivation mechanisms of rod transduction in patients with autosomal dominant retinitis pigmentosa and the pro-23-his mutation. Invest Ophthalmol Vis Sci 1995;36:1603-14.
105. Goto Y, Peachey NS, Ziroli NE, et al. Rod phototransduction in transgenic mice expressing a mutant opsin gene. J Opt Soc Am A Opt Image Sci Vis 1996;13:577-85.
106. Samardzija M, Wenzel A, Naash M, et al. Rpe65 as a modifier gene for inherited retinal degeneration. Eur J Neurosci 2006;23:1028-34.
107. Berson EL. Retinitis pigmentosa: unfolding its mystery. Proc Natl Acad Sci USA 1996;93:4526-8.
108. Mendez A, Burns ME, Roca A, et al. Rapid and reproducible deactivation of rhodopsin requires multiple phosphorylation sites. Neuron 2000;28:153-64.
109. Maeda T, Imanishi Y, Palczewski K. Rhodopsin phosphorylation: 30 years later. Prog Retin Eye Res 2003;22:417-34.
110. Wilden U, Hall SW, Kuhn H. Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments. Proc Natl Acad Sci USA 1986;83:1174-8.
111. Khani SC, Nielsen L, Vogt TM. Biochemical evidence for pathogenicity of rhodopsin kinase mutations correlated with the Oguchi form of congenital stationary night blindness. Proc Natl Acad Sci USA 1998;95:2824-7.
112. Nakamura M, Yamamoto S, Okada M, et al. Novel mutations in the arrestin gene and associated clinical features in Japanese patients with Oguchi's disease. Ophthalmology 2004;111:1410-14.
113. Cideciyan AV, Zhao X, Nielsen L, et al. Null mutation in the rhodopsin kinase gene slows recovery kinetics of rod and cone phototransduction in man. Proc Natl Acad Sci USA 1998;95:328-33.
114. Dryja TP. Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson Memorial Lecture. Am J Ophthalmol 2000;130:547-63.
115. Nakazawa M, Wada Y, Fuchs S, et al. Oguchi disease: phenotypic characteristics of patients with the frequent 1147delA mutation in the arrestin gene. Retina 1997;17:17-22.
116. Nakamachi Y, Nakamura M, Fujii S, et al. Oguchi disease with sectoral retinitis pigmentosa harboring adenine deletion at position 1147 in the arrestin gene. Am J Ophthalmol 1998;125:249-51.
117. Yoshii M, Murakami A, Akeo K, et al. Visual function and gene analysis in a family with Oguchi's disease. Ophthalmic Res 1998;30:394-401.
118. Maw M, Kumaramanickavel G, Kar B, et al. Two Indian siblings with Oguchi disease are homozygous for an arrestin mutation encoding premature termination. Hum Mutat 1998;1:S317-9.
119. Yamamoto S, Khani SC, Berson EL, et al. Evaluation of the rhodopsin kinase gene in patients with retinitis pigmentosa. Exp Eye Res 1997;65:249-53.
120. Fain GL, Lisman JE. Light, Ca2+, and photoreceptor death: new evidence for the equivalent-light hypothesis from arrestin knockout mice. Invest Ophthalmol Vis Sci 1999;40:2770-2.
121. Sieving PA, Fowler ML, Bush RA, et al. Constitutive "light" adaptation in rods from G90D rhodopsin: a mechanism for human congenital nightblindness without rod cell loss. J Neurosci 2001;21:5449-60.
122. Lem J, Fain GL. Constitutive opsin signaling: night blindness or retinal degeneration? Trends Mol Med 2004;10:150-7.
123. Dryja TP, Berson EL, Rao VR, et al. Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nat Genet 1993;4:280-3.
124. al-Jandal N, Farrar GJ, Kiang AS, et al. A novel mutation within the rhodopsin gene (Thr-94-Ile) causing autosomal dominant congenital stationary night blindness. Hum Mutat 1999;13:75-81.
125. Sieving PA, Richards JE, Naarendorp F, et al. Dark-light: model for nightblindness from the human rhodopsin Gly-90→Asp mutation. Proc Natl Acad Sci USA 1995;92:880-4.
126. Rao VR, Cohen GB, Oprian DD. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 1994;367:639-42.
127. Ramon E, del Valle U, Garriga P. Unusual thermal and conformational properties of the rhodopsin congenital night blindness mutant Thr-94→Ile. J Biol Chem 2003;278:6427-32.
128. Gross AK, Rao VR, Oprian DD. Characterization of rhodopsin congenital night blindness mutant T94I. Biochemistry 2003;42:2009-15.
129. Jin S, Cornwall MC, Oprian DD. Opsin activation as a cause of congenital night blindness. Nat Neurosci 2003;6:731-5.
130. Jin M, Li S, Moghrabi WN, et al. Rpe65 is the retinoid isomerase in bovine retinal pigment epithelium. Cell 2005;122:449-59.
131. Moiseyev G, Cher Y, Takahashi Y, et al. RPE65 is the isomerohydrolase in the retinoid visual cycle. Proc Natl Acad Sci USA 2005;102:12413-18.
132. Melia TJ Jr, Cowan CW, Angleson JK, et al. A comparison of the efficiency of G protein activation by ligand-free and light-activated forms of rhodopsin. Biophys J 1997;73:3182-91.
133. Van Hooser JP, Liang Y, Maeda T, et al. Recovery of visual functions in a mouse model of Leber congenital amaurosis. J Biol Chem 2002;277:19173-82.
134. Woodruff ML, Wang Z, Chung HY, et al. Spontaneous activity of opsin apoprotein is a cause of Leber congenital amaurosis. Nat Genet 2003;35:158-64.
135. Ablonczy Z, Crouch RK, Goletz PW, et al. 11-cis-retinal reduces constitutive opsin phosphorylation and improves quantum catch in retinoid-deficient mouse rod photoreceptors. J Biol Cnem 2002;277:40491-8.
136. l36 Aleman TS, Jacobson SG, Chico JD, et al. Impairment of the transient pupillary light reflex in Rpe65(-/-) mice and humans with leber congenital amaurosis. Invest Ophthalmol Vis Sci 2004;45:1259-71.
137. Danciger M, Matthes MT, Yasamura D, et al. A QTL on distal chromosome 3 that influences the severity of light-induced damage to mouse photoreceptors. Mamm Genome 2000;11:422-7.
138. Stargardt K. Uber familiare, progressive degeneration in der maculagegend des auges. Graefes Arch Ophthalmol 1909;71:534-50.
139. Fishman GA, Stone EM, Grover S, et al. Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol 1999;117:504-10.
140. Eagle RC Jr, Lucier AC, Bernardino VB Jr, et al. Retinal pigment epithelial abnormalities in fundus flavimaculatus: a light and electron microscopic study. Ophthalmology 1980;87:1189-200.
141. Bimbach CD, Jarvelainen M, Possin DE, et al. Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology 1994;101:1211-9.
142. Sparrow JR, Boulton M. RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res 2005;80:595-606.
143. Cideciyan AV, Aleman TS, Swider M, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet 2004;13:525-34.
144. Allikmets R, Singh N, Sun H, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 1997;15:236-46.
145. Azarian SM, Travis GH. The photoreceptor rim protein is an ABC transporter encoded by the gene for recessive Stargardt's disease (ABCR). FEBS Lett 1997;409:247-52.
146. Illing M, Molday LL, Molday RS. The 220-kDa rim protein of retinal rod outer segments is a member of the ABC transporter superfamily. J Biol Cnem 1997;272:10303-10.
147. Sun H, Nathans J. Stargardt's ABCR is localized to the disc membrane of retinal rod outer segments. Nat Genet 1997;17:15-16.
148. Molday LL, Robin AR, Molday RS. ABCR expression in foveal cone photoreceptors and its role in Stargardt macular dystrophy. Nat Genet 2000;25:257-8.
149. Rozet JM, Gerber S, Souied E, et al. Spectrum of ABCR gene mutations in autosomal recessive macular dystrophies. Eur J Hum Genet 1998;6:291-5.
150. Martinez-Mir A, Paloma E, Allikmets R, et al. Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR. Nat Genet 1998;18:11-12.
151. Cremers FP, van de Pol DJ, van Driel M, et al. Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR. Hum Mol Genet 1998;7:355-62.
152. Allikmets R, Shroyer NF, Singh N, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997;277:1805-7.
153. Mata NL, Tzekov RT, Liu X, et al. Delayed dark-adaptation and lipofuscin accumulation in abcr+/- mice: implications for involvement of ABCR in age-related macular degeneration. Invest Ophthalmol Vis Sci 2001;42:1685-90.
154. Stone EM, Webster AR, Vandenburgh K, et al. Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration. Nat Genet 1998;20:328-9.
155. Guymer RH, Heon E, Lotery AJ, et al. Variation of codons 1961 and 2177 of the Stargardt disease gene is not associated with age-related macular degeneration. Arch Ophthalmol 2001;119:745-51.
156. Schmidt S, Postel EA, Agarwal A, et al. Detailed analysis of allelic variation in the ABCA4 gene in age-related maculopathy. Invest Ophthalmol Vis Sci 2003;44:2868-75.
157. van Driel MA, Maugeri A, Klevering BJ, et al. ABCR unites what ophthalmologists divide(s). Ophthalmic Genet 1998;19:117-22.
158. Beharry S, Zhong M, Molday RS. N-retinylidene-phosphatidytethanolamine is the preferred retinoid substrate for the photoreceptor-specific ABC transporter ABCA4 (ABCR). J Biol Chem 2004;279:53972-9.
159. Eldred GE, Lasky MR. Retinal age pigments generated by self-assembling lysosomotropic detergents. Nature 1993;361:724-6.
160. Holz FG, Schutt F, Kopitz J, et al. Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. Invest Ophtholmol Vis Sci 1999;40:737-43.
161. Sparrow JR, Parish CA, Hashimoto M, et al. A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. Invest Ophthalmol Vis Sci 1999;40:2988-95.
162. Sparrow JR, Nakanishi K, Parish CA. The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 2000;41:1981-9.
163. Suter M, Reme C, Grimm C, et al. Age-related macular degeneration. The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J Biol Chem 2000;275:39625-30.
164. Finnemann SC, Leung LW, Rodriguez-Boulan E. The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc Natl Acad Sci USA 2002;99:3842-7.
165. Sparrow JR, Fishkin N, Zhou J, et al. A2E, a byproduct of the visual cycle. Vis Res 2003;43:2983-90.
166. Weleber RG, Denman ST, Hanifin JM, et al. Abnormal retinal function associated with isotretinoin therapy for acne. Arch Ophthalmol 1986;104:831-7.
167. Law WC, Rondo RR. The molecular basis of retinoic acid induced night blindness. Biochem Biophys Res Commun 1989;161:825-9.
168. Sieving PA, Chaudhry P, Kondo M, et al. Inhibition of the visual cycle in vivo by 13-cis retinoic acid protects from light damage and provides a mechanism for night blindness in isotretinoin therapy. Proc Natl Acad Sci USA 2001;98:1835-40.
169. Radu RA, Mata NL, Nusinowitz S, et al. Treatment with isotretinoin inhibits lipofuscin accumulation in a mouse model of recessive Stargardt's macular degeneration. Proc Natl Acad Sci USA 2003;100:4742-7.
170. Golczak M, Kuksa V, Maeda T, et al. Positively charged retinoids are potent and selective inhibitors of the trans-cis isomerization in the retinoid (visual) cycle. Proc Natl Acad Sci USA 2005;102:8162-7.
171. Radu RA, Han Y, Bui TV, et al. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest Ophthalmol Vis Sci 2005;46:4393-401.
172. Maiti P, Kong J, Kim SR, et al. Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation. Biochemistry 2006;45:852-60.